Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/2014
06/03/2014US8741869 Oligodeoxynucleotide and its use to induce an immune response
06/03/2014US8741812 Class of sterol ligands and their uses in regulation of cholesterol and gene expression
06/03/2014US8741810 In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells
06/03/2014US8741639 Method for producing dendritic cells
06/03/2014US8741576 Heteroclitic analogs and related methods
06/03/2014US8741351 Microspheres for active embolization
06/03/2014US8741315 Methods of treating tumors in immune-privileged sites
06/03/2014US8741314 Multivalent meningococcal polysaccharide-protein conjugate vaccine
06/03/2014US8741313 Polypeptide vaccine and vaccination strategy against mycobacterium
06/03/2014US8741312 High yield yellow fever virus strain with increased propagation in cells
06/03/2014US8741311 Methods and compositions for immunization against virus
06/03/2014US8741310 Fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies
06/03/2014US8741309 Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142
06/03/2014US8741308 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
06/03/2014US8741306 Kidney specific tumor vaccine directed against kidney tumor antigen G-250
06/03/2014US8741305 Protein composition for inducing an immune response in a vertebrate comprising a plurality of protein variants covering the heterogeneity of a single antigen, AMA1
06/03/2014US8741304 Chimeric vaccine for Haemophilus influenzae-induced disease
06/03/2014US8741303 Immunogenic LHRH compositions and methods relating thereto
06/03/2014US8741302 Polypeptide derived from Enterococcus and its use for vaccination
06/03/2014US8741301 Method for generation of RNA virus
06/03/2014US8741299 Method for treating pathologies associated with hypoxia using MIF inhibitors
06/03/2014US8741298 APOE immunotherapy
06/03/2014US8741297 Preparation of isolated agonist anti-EDAR monoclonal antibodies
06/03/2014US8741295 PD-1 antibodies and PD-L1 antibodies and uses thereof
06/03/2014US8741294 Anti-CεmX antibodies capable of binding to human mIgE on B lymphocytes
06/03/2014US8741293 Naturally occurring autoantibodies against alpha-synuclein that inhibit the aggregation and cytotoxicity of alpha-synuclein
06/03/2014US8741292 Proteins and methods for modulating cell activity
06/03/2014US8741290 Anti-cMet antibody
06/03/2014US8741289 Siglec 15 antibodies in treating bone loss-related disease
06/03/2014US8741288 Protein markers for detecting liver cancer and method for identifying the markers thereof
06/03/2014US8741287 PlGF-1 assay and kits and components thereof
06/03/2014US8741260 Fusion proteins for delivery of GDNF to the CNS
06/03/2014CA2706101C A powerful vaccine composition comprising a lipopeptide and poly i:c as an adjuvant
06/03/2014CA2692744C Apparatus and method for harvesting biologics from eggs
06/03/2014CA2649538C Buffering agents for biopharmaceutical formulations
06/03/2014CA2606871C Use of native peptides and their optimized derivatives for vaccination
06/03/2014CA2592439C Rescue of influenza virus
06/03/2014CA2586620C Multivalent vaccines comprising recombinant viral vectors
06/03/2014CA2563313C Modulation of nkg2d
06/03/2014CA2548149C Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
06/03/2014CA2496795C Compositions and methods for treating cardiovascular disease
06/03/2014CA2443995C Endothelial cell expression patterns
06/03/2014CA2434490C Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions
05/2014
05/30/2014WO2014081955A1 Heterodimeric immunoglobulins
05/30/2014WO2014081856A2 Ligands that target hcv-e2 binding sites on cd81 and therapeutic methods using them
05/30/2014WO2014081712A2 Methods of treating a disease or disorder associated with bruton's tyrosine kinase
05/30/2014WO2014081709A2 Methods of treating a disease or disorder associated with bruton's tyrosine kinase
05/30/2014WO2014081398A1 Biotinylated protein
05/30/2014WO2014081202A1 Dual-target antibody targeting vegfr-2 and dll4, and pharmaceutical composition comprising same
05/30/2014WO2014080866A1 Novel human antibody against il-18
05/30/2014WO2014080350A1 Immunomodulatory peptides and methods of use thereof
05/30/2014WO2014080063A1 Recombinant protein and uses thereof in the diagnosis of multiple sclerosis
05/30/2014WO2014079886A1 Anti-ceacam5 antibodies and uses thereof
05/30/2014WO2014079842A1 Rsv f prefusion trimers
05/30/2014WO2014079000A1 Bispecific antibody
05/30/2014WO2014078963A1 Anti-lg3 antibody inhibition in the prevention and/or treatment of vascular rejection and related diseases and conditions
05/30/2014WO2014055999A3 Treatment of ocular disorders
05/30/2014WO2014053861A3 Staphylococcus aureus antigens
05/30/2014WO2014039978A3 Vaccine to prevent mycoplasmal infection in waterfowl
05/30/2014WO2014022835A3 PEPTIDE VACCINES BASED ON THE EGFRvIII SEQUENCE FOR THE TREATMENT OF TUMORS
05/30/2014WO2014022475A8 Compositions and methods for conformationally stabilizing primate immunodeficiency virus envelope glycoprotein trimers
05/30/2014WO2014016383A9 Glycoproteins for pseudotyping lentivectors
05/30/2014WO2014015116A3 Arterivirus protein and expression mechanisms
05/30/2014WO2014012007A4 Rspo3 binding agents and uses thereof
05/30/2014WO2013186639A3 Methylation biomarkers for breast cancer
05/30/2014WO2013184912A4 Binding agents that modulate the hippo pathway and uses thereof
05/30/2014WO2013059439A3 Combination therapy comprising an mmp-14 binding protein
05/30/2014WO2013059322A3 Amyloid beta peptide as a therapy for inflammation
05/29/2014US20140147490 Hla class i a2 tumor associated antigen peptides and vaccine compositions
05/29/2014US20140147475 Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
05/29/2014US20140147469 Process for detergent-free production of outer membrane vesicles of a gram-negative bacterium
05/29/2014US20140147468 Lprg as a chaperone of immune adjuvants
05/29/2014US20140147466 Recombinant low virulence bovine herpesvirus-1 (bohv-1) vaccine vectors
05/29/2014US20140147465 Recombinant gallid herpesvirus 3 (mdv serotype 2) vectors expressing antigens of avian pathogens and uses thereof
05/29/2014US20140147463 Vaccine against rsv
05/29/2014US20140147459 Computationally optimized broadly reactive antigens for h1n1 influenza
05/29/2014US20140147454 Terminally modified rna
05/29/2014US20140147448 Novel compositions and methods of preventing or ameliorating abnormal thrombus formation and cardiovascular disease
05/29/2014US20140147445 Selective Targeting of the CD40L/Mac-1 Interaction by Small Peptide Inhibitors and its Use for the Treatment of Inflammation and Atherogenesis
05/29/2014US20140147444 Selective binding agents of osteoprotegerin binding protein
05/29/2014US20140147443 Compositions and methods for diagnosing and treating cancer
05/29/2014US20140147441 Compositions containing alpha-1-antitrypsin and methods for use
05/29/2014US20140147440 Uses of nanog inhibitors and related methods
05/29/2014US20140147434 NCoR1 is a Physiological Modulator of Muscle Mass and Oxidative Function
05/29/2014US20140147413 Therapies That Target Autoimmunity For Treating Glaucoma And Optic Neuropathy
05/29/2014US20140147411 Methods of treating cancer and testing mutation zygosity related thereto
05/28/2014EP2735315A1 Stable protein-containing preparation containing argininamide or analogous compound thereof
05/28/2014EP2735314A1 Improved sugar-coated liposome composition
05/28/2014EP2734614A1 Isolated brachyspira and methods and compositions for expanding and isolating brachyspira
05/28/2014EP2734551A1 Variants of humanized immunomodulatory monoclonal antibodies
05/28/2014EP2734550A1 A topical composition for the treatment of alopecia
05/28/2014EP2734547A1 Use of c-fms antagonists
05/28/2014EP2734546A1 Apelin antigen-binding proteins and uses thereof
05/28/2014EP2734539A1 Prame purification
05/28/2014EP2734270A1 Attenuated plasmodium with the hmgb2 gene inactivated as a vaccine
05/28/2014EP2734240A2 Protection of cells from alu-rna-induced degenereation and inhibitors for protecting cells
05/28/2014EP2734236A2 Methods and compositions for treating asthma using anti-il-13 antibodies
05/28/2014EP2734235A1 Ruthenium carbon monoxide releasing molecules and uses thereof
05/28/2014EP2734234A2 Anti-cxcr4 antibodies and methods of use
05/28/2014EP2734233A1 Methods of predicting host responsiveness to cancer immunotherapies by ex vivo induction of leukocyte-function-associated mrnas
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 1823